Top Buy Stocks
Sign In
NASDAQ:AVGR
Delisted
Avinger Stock News
Invest in AVGR
$0.474
+0 (+0%)
At Close: May 13, 2025
Avinger, Inc. Executes Assignment for the Benefit of Creditors; Announces Receipt of Nasdaq Delisting Notice
07:33pm, Monday, 17'th Feb 2025
SANTA CLARA, CALIFORNIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- On February 10, 2025, Avinger, Inc., a Delaware Corporation (“Avinger” or the “Company”), entered into a general assignment for the b
Avinger, Inc. (AVGR) Q3 2024 Earnings Call Transcript
09:43pm, Thursday, 07'th Nov 2024
Avinger, Inc. (NASDAQ:AVGR ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Matthew Kreps - Investor Relations Jeffrey Soinski - Chief Executive Officer Nabeel Subai
Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates
06:37pm, Thursday, 07'th Nov 2024
Avinger (AVGR) came out with a quarterly loss of $1.82 per share versus the Zacks Consensus Estimate of a loss of $2.03. This compares to loss of $2.92 per share a year ago.
Avinger Reports Third Quarter 2024 Results
04:05pm, Thursday, 07'th Nov 2024
Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device comp
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
08:00am, Tuesday, 29'th Oct 2024
REDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
08:00am, Thursday, 24'th Oct 2024
REDWOOD CITY, CA / ACCESSWIRE / October 24, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
08:00am, Wednesday, 18'th Sep 2024
REDWOOD CITY, CA / ACCESSWIRE / September 18, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based syst
Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment
12:15pm, Wednesday, 21'st Aug 2024
Avinger (AVGR) fully launches Pantheris LV, the first image-guided atherectomy system for large vessels, thus enhancing peripheral artery disease treatment with advanced technology.
Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device
08:30am, Tuesday, 20'th Aug 2024
REDWOOD CITY, CA / ACCESSWIRE / August 20, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system
Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript
12:42pm, Friday, 09'th Aug 2024
Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript
Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates
06:20pm, Thursday, 08'th Aug 2024
Avinger (AVGR) came out with a quarterly loss of $2.82 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $8.85 per share a year ago.
Avinger Reports Second Quarter 2024 Results
04:01pm, Thursday, 08'th Aug 2024
Implements Lower Operating Cost Profile, Readying OCT-Guided Coronary Device for IDE Submission REDWOOD CITY, CA / ACCESSWIRE / August 8, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
08:00am, Monday, 05'th Aug 2024
REDWOOD CITY, CA / ACCESSWIRE / August 5, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
08:45am, Monday, 29'th Jul 2024
REDWOOD CITY, CA / ACCESSWIRE / July 29, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system fo
Avinger Announces Closing of up to $24 Million Public Offering
04:05pm, Monday, 17'th Jun 2024
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 17, 2024
